(2010). Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors.
(2002). Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system. Methods
(2002). Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science
(2002). al: A DNA vectorbased RNAi technology to suppress gene expression in mammalian cells.
(2003). al: Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep
(2003). al: The astrocyte/meningeal cell interface is a barrier to neurite outgrowth which can be overcome by manipulation of inhibitory molecules or axonal signalling pathways. Mol Cell Neurosci
(2009). BL: Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther
(2003). BR: Activation of the interferon system by short-interfering RNAs. Nat Cell Biol
(2003). BR: Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev
(2005). BR: Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA
(2006). Chemorepellent axon guidance molecules in spinal cord injury.
(2007). Class A plexin expression in axotomized rubrospinal and facial motoneurons. Neuroscience
(2008). DA: Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites. Proc Natl Acad Sci USA
(2007). Defining the optimal parameters for hairpin-based knockdown constructs. RNA
(1996). Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev
(2009). Dose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neurons. Mol Ther
(2002). DS: Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev
(2006). et al: A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med
(2008). et al: Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA
(2006). et al: Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature
(2004). et al: Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res
(1996). et al: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science
(2008). et al: Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems. Restor Neurol Neurosci
(2000). et al: Peripheral, but not central, axotomy induces neuropilin-1 mRNA expression in adult large diameter primary sensory neurons.
(1998). Evidence for a role of the chemorepellent semaphorin III and its receptor neuropilin-1 in the regeneration of primary olfactory axons.
(2008). Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Mol Ther
(2002). Gene silencing using micro-RNA designed hairpins. RNA
Huseinovic A, et al: Comparison of AAV Serotypes for Gene Delivery to Dorsal Root Ganglion Neurons. Mol Ther .
(2003). Iggo R: Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet